Organon & Co. - 10-Q Filing
Organon & Co. reports Q3 2026 financial results and updates on collaborative arrangements with Shanghai Henlius Biotech and Sebela Pharmaceutical.
Tickers: $OGN
Organon & Co. reports Q3 2026 financial results and updates on collaborative arrangements with Shanghai Henlius Biotech and Sebela Pharmaceutical.
Tickers: $OGN